ICRM
ANAC

Insight Capital Research & Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Insight Capital Research & Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-188,041
Closed -$3.76M – 171
2014
Q1 		$3.76M Sell
188,041
-6,452
-3% -$125K 0.87% 52
2013
Q4 		$3.26M Buy
+194,493
New +$2.69M 0.73% 55

Other funds holding ANAC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Insight Capital Research & Management's ANAC Position: Q2 2014 in Review

Insight Capital Research & Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2014, closing a stake of 188,041 shares — an estimated $3.76M sold.

Insight Capital Research & Management first reported a position in ANAC in Q4 2013 and held it in 2 quarters. The position peaked at $3.76M in Q1 2014. 107 funds tracked by Wall St. Rank hold ANAC as of Q2 2014.

  • Insight Capital Research & Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2014 after selling out during the quarter.
  • Insight Capital Research & Management sold 188,041 ANACOR PHARMACEUTICALS INC COM shares in Q2 2014, an estimated $3.76M.
  • Insight Capital Research & Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 2 quarters.
  • Insight Capital Research & Management's ANACOR PHARMACEUTICALS INC COM position peaked at $3.76M in Q1 2014.
  • 107 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2014.

Based on Insight Capital Research & Management's 13F filing for Q2 2014, filed 13 Aug 2014.